Summary
Frederick Banting’s 1929 book “The History of Insulin” provides a firsthand account of the discovery and early clinical application of insulin, written by the co-discoverer himself. The central thesis is that the isolation of insulin from pancreatic islets was a systematic scientific breakthrough that transformed diabetes from a fatal diagnosis into a manageable chronic condition. Banting details the key experiments at the University of Toronto, including the ligation of dog pancreases to extract the active hormone, and the subsequent purification with biochemist Charles Best. He also covers the first human trials on Leonard Thompson in 1922, the scaling of production with Eli Lilly, and the awarding of the Nobel Prize in 1923. The book emphasizes the collaborative nature of the work and the urgent need to make insulin widely available. A reader takes away a clear, technical understanding of how insulin was discovered and the immediate impact on diabetic patients.
Full text isn't indexed yet — this overview draws on general knowledge of the book and its metadata, and chat works the same way.
Key concepts
- Pancreatic duct ligation — A surgical technique used by Banting to degenerate the exocrine pancreas, leaving the islets of Langerhans intact for insulin extraction.
- Isletin — The original name Banting and Best gave to the pancreatic extract before it was renamed insulin.
- Leonard Thompson — The first human patient to receive a successful injection of purified insulin in January 1922, dramatically lowering his blood sugar.
- Nobel Prize in Physiology or Medicine 1923 — Awarded to Banting and John Macleod, which Banting shared with Best and Macleod shared with Collip, reflecting the collaborative discovery.
- Eli Lilly and Company — The pharmaceutical company that partnered with the University of Toronto to mass-produce insulin starting in 1923.